Skip to content

Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients

Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00485706
Enrollment
Unknown
Registered
2007-06-13
Start date
2007-06-30
Completion date
Unknown
Last updated
2018-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercalcemia, Kidney Disease

Keywords

dialysis, vascular calcification, bone mineralism, arterial stiffness, bone metabolism, chronic kidney disease

Brief summary

Renal patients have an increased risk for cardiovascular complications. There is also increased vascular calcification and bone metabolism is similarly abnormal in patients with chronic kidney disease. In dialysis patients frequent episodes of hypercalcaemia occur. In a healthy bone structure those episodes of hypercalcemia are buffered by the bone. The absence of bone buffering capacity in dialysis patients can be a mechanism for vascular calcifications.

Detailed description

Study hypothesis. Patient with a higher ∆ Calcium (Calcium post - Calcium pre) have a diminished bone buffering capacity indicative for adynamic bone disease compared with patients with smaller ∆ Calcium. This may result in higher extraosseous calcification and higher pulse wave velocity ∆ PTH/∆ Calcium may reflect the sensitivity and density of the calcium receptors; this may reflect parathyroid health

Interventions

PROCEDUREhigh calcium dialysate

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* maintenance hemodialysis patients

Exclusion criteria

* dialysis \<3 months * aortobifemoral graft * calcium level predialysis \>10.5 mg/dl

Design outcomes

Primary

MeasureTime frameDescription
correlation between calcium increase and pulse wave velocitycorrelation between calcium increase and pulse wave velocity
correlation between calcium change and pth changecorrelation between calcium change and pth change

Secondary

MeasureTime frameDescription
correlation between calcium increase and vascular calcificationscorrelation between calcium increase and vascular calcifications
correlation between calcium change and bone markerscorrelation between calcium change and bone markers

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026